Medpace Holdings Price to Book Ratio 2014-2025 | MEDP
Historical price to book ratio values for Medpace Holdings (MEDP) over the last 10 years. The current price to book ratio for Medpace Holdings as of April 23, 2025 is 11.15.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Medpace Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-04-23 | 290.54 | 10.78 | |
| 2024-12-31 | 332.23 | $26.95 | 12.33 |
| 2024-09-30 | 333.80 | $28.36 | 11.77 |
| 2024-06-30 | 411.85 | $24.63 | 16.72 |
| 2024-03-31 | 404.15 | $21.67 | 18.65 |
| 2023-12-31 | 306.53 | $18.18 | 16.86 |
| 2023-09-30 | 242.13 | $15.35 | 15.78 |
| 2023-06-30 | 240.17 | $12.80 | 18.77 |
| 2023-03-31 | 188.05 | $11.34 | 16.58 |
| 2022-12-31 | 212.41 | $12.43 | 17.09 |
| 2022-09-30 | 157.17 | $11.25 | 13.97 |
| 2022-06-30 | 149.67 | $9.14 | 16.37 |
| 2022-03-31 | 163.59 | $17.98 | 9.10 |
| 2021-12-31 | 217.64 | $26.47 | 8.22 |
| 2021-09-30 | 189.28 | $24.99 | 7.57 |
| 2021-06-30 | 176.63 | $23.78 | 7.43 |
| 2021-03-31 | 164.05 | $23.91 | 6.86 |
| 2020-12-31 | 139.20 | $22.69 | 6.14 |
| 2020-09-30 | 111.75 | $22.14 | 5.05 |
| 2020-06-30 | 93.02 | $20.84 | 4.46 |
| 2020-03-31 | 73.38 | $20.23 | 3.63 |
| 2019-12-31 | 84.06 | $20.14 | 4.17 |
| 2019-09-30 | 84.04 | $19.22 | 4.37 |
| 2019-06-30 | 65.42 | $18.33 | 3.57 |
| 2019-03-31 | 58.97 | $17.41 | 3.39 |
| 2018-12-31 | 52.93 | $16.53 | 3.20 |
| 2018-09-30 | 59.91 | $15.77 | 3.80 |
| 2018-06-30 | 43.00 | $15.19 | 2.83 |
| 2018-03-31 | 34.91 | $14.48 | 2.41 |
| 2017-12-31 | 36.26 | $14.20 | 2.55 |
| 2017-09-30 | 31.90 | $14.71 | 2.17 |
| 2017-06-30 | 29.00 | $15.30 | 1.90 |
| 2017-03-31 | 29.85 | $15.27 | 1.96 |
| 2016-12-31 | 36.07 | $15.02 | 2.40 |
| 2016-09-30 | 29.86 | $15.00 | 1.99 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.956B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| Natera (NTRA) | United States | $20.018B | 0.00 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| Revvity (RVTY) | United States | $11.032B | 18.74 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Doximity (DOCS) | United States | $9.934B | 51.66 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| HealthEquity (HQY) | United States | $7.311B | 35.97 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |